Skip to main content
KMTS
NASDAQ Life Sciences

ASSURE Defibrillator Study Meets Endpoints; All 303 Shock Events Converted

Tom Rudovsky · Reported by Wiseek News
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$28.64
Mkt Cap
$1.706B
52W Low
$17.34
52W High
$31.99
52W Position info
65% above low
Off High info
10% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

KMTS sits 65% above its 52-week low of $17.34.

Summary

Kestra's 21,612-patient ASSURE wearable defibrillator study met its primary safety and effectiveness endpoints, and the results are now published. The ACE-PAS analysis converted all 303 analyzable VT/VF shock events, with an inappropriate-shock rate of 0.0065 per patient-month and 94% of patients free of false alarms. That is the clinical evidence base the wearable cardioverter-defibrillator franchise needs to support adoption and reimbursement. Analysts lifted their average 12-month price target to $31.12, about 8% above the current $28.64, with consensus still Buy (eight Buy, one Hold). This lands after the September 14 8-K showing F1Q27 revenue of $31.0 million, up 60% year-over-year, and a raised FY27 outlook of $141 million — the clinical data reinforces that growth story rather than changing it. The offset remains the material weaknesses in internal controls disclosed in the September 10-Q.

At the time of this announcement, KMTS was trading at $28.64 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $17.34 to $31.99. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

KMTS - Latest Insights

KMTS
Sep 14, 2026, 5:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $21.70
Real-time Price: $27.78 info
Change: +$6.08 (+28%) info
Market Cap: $1.658B info
KMTS
Sep 14, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $23.16
Real-time Price: $27.78 info
Change: +$4.62 (+20%) info
Market Cap: $1.658B info
KMTS
Sep 14, 2026, 4:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $24.00
Real-time Price: $27.78 info
Change: +$3.78 (+16%) info
Market Cap: $1.658B info
KMTS
Jul 14, 2026, 5:16 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $24.22
Real-time Price: $27.78 info
Change: +$3.56 (+15%) info
Market Cap: $1.658B info
KMTS
Jul 14, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $24.18
Real-time Price: $27.78 info
Change: +$3.60 (+15%) info
Market Cap: $1.658B info